Investing in innovative drugs generates 467% financial gains
According to the European pharmaceutical industry federation, investments in innovative drugs generate an average financial return of 467%.
Published 4sem1 sourceNotableupdated 4sem
Lire en français
≈ 26s
The fact
This study underscores the economic attractiveness of the sector for institutional and private investors in a context of shift toward personalized treatments.
The European pharmaceutical sector thus advocates for maintaining a favorable regulatory environment to continue therapeutic innovation.
Click the link to read an article on the topic: